No Data
Guizhou Xinbang Pharmaceutical (002390.SZ): The PET-CT system used by the Affiliated Tumor Hospital of Guizhou Medical University is a product of GE from the USA.
According to Gelonghui on December 31, Guizhou Xinbang Pharmaceutical (002390.SZ) stated on the investor interaction platform that the PET-CT used by its subsidiary, Guizhou Medical University Affiliated Cancer Hospital Co., Ltd., is a product of GE Company from the USA.
Guizhou Xinbang Pharmaceutical Co., Ltd.'s (SZSE:002390) Stock Is Going Strong: Have Financials A Role To Play?
Guizhou Xinbang Pharmaceutical Co., Ltd. (SZSE:002390) Surges 9.6%; Retail Investors Who Own 51% Shares Profited Along With Insiders
Xinbang Pharmaceuticals: Report for the third quarter of 2024
Guizhou Xinbang Pharmaceutical (002390.SZ) released its performance for the first three quarters, with a net income of 0.177 billion yuan, a year-on-year decrease of 28.38%.
Guizhou Xinbang Pharmaceutical (002390.SZ) released its third quarter report for 2024. In the first three quarters, the company achieved revenue...
Guizhou Xinbang Pharmaceutical (SZSE:002390) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Three Years, but the Stock Increases 7.7% This Past Week
Earnings Growth of 1.1% Over 3 Years Hasn't Been Enough to Translate Into Positive Returns for Guizhou Xinbang Pharmaceutical (SZSE:002390) Shareholders
